Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs
作者： L. Nicole Harrison , Dan Zheng , Maya Lottati , Isabel R. Hsu , Stella P. Kim
DOI: 10.1152/AJPENDO.90972.2008
关键词:
摘要: We investigated whether rimonabant, a type 1 cannabinoid receptor antagonist, reduces visceral adipose tissue (VAT) and subcutaneous (SAT) in dogs maintained on hypercaloric high-f...
sci-hub.se 参考文章(49)
Torbjörn U.C. Järbe, Matthew E. Andrzejewski, Nicholas V. DiPatrizio, Interactions between the CB1 receptor agonist Δ9-THC and the CB1 receptor antagonist SR-141716 in rats: Open-field revisited Pharmacology, Biochemistry and Behavior. ,vol. 73, pp. 911- 919 ,(2002) , 10.1016/S0091-3057(02)00938-3
Bradford B. Lowell, Bruce M. Spiegelman, Towards a molecular understanding of adaptive thermogenesis. Nature. ,vol. 404, pp. 652- 660 ,(2000) , 10.1038/35007527
Luc F Van Gaal, Aila M Rissanen, André J Scheen, Olivier Ziegler, Stephan Rössner, None, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study The Lancet. ,vol. 365, pp. 1389- 1397 ,(2005) , 10.1016/S0140-6736(05)66374-X
Samuel Klein, Luigi Fontana, V. Leroy Young, Andrew R. Coggan, Charles Kilo, Bruce W. Patterson, B. Selma Mohammed, Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease The New England Journal of Medicine. ,vol. 350, pp. 2549- 2557 ,(2004) , 10.1056/NEJMOA033179
B. Selma Mohammed, Samuel Cohen, Dominic Reeds, V. Leroy Young, Samuel Klein, Long-term effects of large-volume liposuction on metabolic risk factors for coronary heart disease. Obesity. ,vol. 16, pp. 2648- 2651 ,(2008) , 10.1038/OBY.2008.418
F. Xavier Pi-Sunyer, Louis J. Aronne, Hassan M. Heshmati, Jeanne Devin, Julio Rosenstock, for the RIO-North America Study Group, Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients JAMA. ,vol. 295, pp. 761- 775 ,(2006) , 10.1001/JAMA.295.7.761
D. G. Carey, A. B. Jenkins, L. V. Campbell, J. Freund, D. J. Chisholm, Abdominal Fat and Insulin Resistance in Normal and Overweight Women: Direct Measurements Reveal a Strong Relationship in Subjects at Both Low and High Risk of NIDDM Diabetes. ,vol. 45, pp. 633- 638 ,(1996) , 10.2337/DIAB.45.5.633
Claudio Pagano, Catia Pilon, Alessandra Calcagno, Riccardo Urbanet, Marco Rossato, Gabriella Milan, Katiuscia Bianchi, Rosario Rizzuto, Paolo Bernante, Giovanni Federspil, Roberto Vettor, The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. The Journal of Clinical Endocrinology and Metabolism. ,vol. 92, pp. 4810- 4819 ,(2007) , 10.1210/JC.2007-0768
Abdul Hamid Zargar, Mohammad Iqbal Sheikh, Mir Iftikhar Bashir, Shariq Rashid Masoodi, Bashir Ahmad Laway, Arshad Iqbal Wani, Mohammad Hayat Bhat, Farooq Ahmad Dar, None, Prevalence of gestational diabetes mellitus in Kashmiri women from the Indian subcontinent. Diabetes Research and Clinical Practice. ,vol. 66, pp. 139- 145 ,(2004) , 10.1016/J.DIABRES.2004.02.023
B. Poirier, J.-P. Bidouard, C. Cadrouvele, X. Marniquet, B. Staels, S. E. O'Connor, P. Janiak, J.-M. Herbert, The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes, Obesity and Metabolism. ,vol. 7, pp. 65- 72 ,(2005) , 10.1111/J.1463-1326.2004.00374.X